Introduction
Neurodevelopmental disorders among childhood have increased significantly over the past several decades worldwide. In 2014, Centers for Disease Control and Prevention of United States estimated that one out of 68 children show autism spectrum disorder (ASD) 1) . This number is very high, compared to the old statistics, e.g., 1 out of 150 children in 2007, and 1 out of 2,500 in 1985 2) . In addition, up to 20% of children, depending on country, exhibit attention deficiency hyperactivity disorders 3) . Aggressive diagnosis and reporting may explain this phenomenal upsurge of the neurodevelopmental disorders to certain extent. However, importance of environmental causes gains more recognition as determinants of these diseases among the scientists. For example, environmental contaminants are suggested as major causes of ASD, along with diagnostic accretion, greater awareness, and age of parents 2) . Thyroid hormones are involved in regulation of various processes over early brain development 4) . These hormones are involved in dendritic and axonal growth, neurogenesis, and myelination processes in developing fetus during pregnancy. After birth as well, these hormones are important in myelination of neurons. Therefore, even subclinical changes of thyroid hormones during these susceptible periods of life may lead to delays in neuropsychological development of children 5) . Numerous observational studies support the importance of thyroid hormones in neurodevelopment of children. Infants with low thyroxine (T4) showed modestly increase risk of ASD in large scale population study in California United States 6) . According to the observations of a prospective cohort study on Dutch mother-child pairs (n=3,839), when the levels free triiodothyronine (T3) of mother were too high or low, the average intelligence quotient (IQ) of her child was lower by 1.4-3.8 7) . As fetal thyroid gland is not sufficiently developed until second trimester of pregnancy, development of fetus will be likely influenced by maternal thyroid hormones. Therefore, the factors that will affect not only thyroid hormones of the infants but also those of pregnant mothers can affect the IQ and neurodevelopment of the children.
Thyroid disrupting chemicals (TDCs) are suggested to be responsible for, to certain extent, rapid increase of neurodevelopmental diseases worldwide. Numerous chemicals are reported to disrupt thyroid hormone balances. These chemicals include phthalates and phenolic compounds that are widely used in daily life, and persistent organic compounds such as organochlorine pesticides (OCPs), polychlorinated biphenyls (PCBs), polybrominated diphenylethers (PBDEs), and perfluoroalkyl substances (PFASs) 8) .
Perfluoroalkyl substances
PFASs are reported to disrupt thyroid hormone balances by increasing metabolic excretion and inhibiting synthesis of the hormones 9) . Unlike other persistent organic compounds which preferentially partition into lipid, PFASs are unique as these compounds can resist both water and oil. This characteristic is due to their structure with perfluorinated carbon tail and . www.e-apem.org polar head 10) . For this property, PFASs have been widely used as surfactants and surface coatings in various applications in industry and commerce since 1950s, such as textiles, food contact paper, cookware, carpets, cosmetics, photographic emulsifiers, lubricants, paints, fire-fighting foams, and food packaging 11, 12) . PFASs are highly fluorinated synthetic aliphatic substances of which H substituents are replaced by F (CnF 2n+1-). Major PFASs are shown in Table 1 11, [13] [14] [15] [16] [17] [18] [19] [20] [21] and Fig. 1 . By the component, PFASs are grouped into perfluoroalkyl sulfonic acids (PFSAs) and perfluoroalkyl carboxylic acids (PFCAs). Generally longer carbon chain PFASs, e.g., long-chain PFSAs (number of C ≥6) and PFCAs (number of C ≥7), are reported to be more bioaccumulative and persistent compared to the short-chain PFASs 11) . Definition of long-chain is different for PFCAs and PFSAs, as PFSA with 6 carbons (perfluorohexane sulfonic acid [PFHxS] ) is more bioaccumulative than perfluorohexanoic acid (PFHxA).
Recently, heavily used long-chain PFASs such as perfluorooctane sulfonic acid (PFOS) have been phased out, and shorter carbon chain PFASs have been used as replacements in increasing amount 22) . Therefore, the occurrence of the substitutes in both environment and biota has increased worldwide. In breastmilk samples of Korean lactating women (n=265), while perfluorooctanoic acid (PFOA) and PFOS were detected in 98.5% of the samples, short carbon chain PFASs such as perfluoropentanoic acid (PFPeA), PFHxA, and perfluoroheptanoic acid, were detected in high frequency ranging between 67.4% and 81.8%. The levels of PFPeA and PFHxA in breastmilk were the greatest compared to the previous reports suggesting that these compounds that replace the long chain PFASs are used in increasing amount over time 23) . Longer carbon chain PFASs (number of C ≥9) are used also in growing amount. Reflecting this trend, in Australia, the serum levels of PFOS and PFOA showed decreasing trend between 2002 and 2013, but perfluorododecanoic acid (PFDoDA) showed an increase 24) .
Biological half-lives of PFASs
Because of the different composition and chain length, biological half-lives of PFASs vary by structure. Long-chain compounds like PFHxS, PFOS, and PFOA have longer half-lives than the PFASs with shorter carbon chains 16) . For example, halflife of serum PFOA is estimated up to 8.5 years, but those for perfluorobutanoic acid and PFHxA are ranging between 3 and 28 days 13, 14) . Biological half-lives of other short-chain PFASs are also expected to be relatively short.
PFASs exposure and thyroid hormone disruption in general populations
Association studies on general population without occupational exposure are accumulating. Several big scale studies employing nationally representative populations are also conducted. In addition, studies on susceptible human populations such as pregnant women and newborns or children are conducted. Reports on nationally representative human populations are mostly based on US National Health and Nutrition Examination Survey (NHANES). Among general US population, PFOS, PFOA, PFHxS, and perfluorononanoic acid (PFNA) are most frequently measured and reported. The exposure to these chemicals showed significant association with thyroid hormone levels ( Table 2) 25 -29) . Among adults with current thyroid diseases, PFOA or PFOS were detected at relatively higher levels 25) . While many PFASs www.e-apem.org showed significant associations with thyroid hormone levels, the directions of association were different by sex 26) , and age 27) . According to the survey 2007-2010, the PFOA and PFHxS levels showed positive associations with total thyroid hormones among female (n=509), however, among male population (n=672), negative association was observed between PFHxS and free T4 (fT4) levels 26) . Among the adolescents in the 2011-2012 survey, males (n=158) showed positive associations between PFOS or PFNA and thyroid stimulating hormone (TSH), while females (n=145) showed a negative association between PFOA and TSH 27) . In the same survey round (NHANES, 2011-2012), effects of age were also observed. Female subjects of 20 to 40 years of age (n=268) showed positive associations between study PFASs, i.e., PFOA, PFHxS, PFNA, or PFOS, and TSH. However, among females of 60 to 80 years of age, a negative association between PFHxS and TSH was observed 27) . By levels of thyroid peroxidase (TPO) antibody (Ab) and urinary iodine, the association between PFASs and thyroid hormones differs 28) . In NHANES 2007-2008, subjects with normal levels of TPOAb and urinary iodine (n=1,012) exhibited a positive association between PFOA and free T3. However, among those who showed abnormal range of these markers (n=26) negative associations were observed between PFHxS or PFOA and fT4 28) . While it was not nationally representative sampling, among general Korean populations (>12 years of age, n=644), Ji et al. 30) reported a negative association of perfluorotridecanoic acid with tT4, and a positive association with TSH, in a small industrial city of Siheung, Korea.
The influences of sex and age on the reported associations may be due to the biological half-lives of PFASs. The biological half-lives of major PFASs tend to be shorter among females, probably because of menstruation 31) . The fact that post-menopausal women, e.g., women of 60-80 years of age, showed different direction of association compared to menstruating women 27) , may also support this hypothesis. In addition, the interaction between sex hormones and thyroid hormones cannot be excluded. Several human thyroid disorders are accompanied by changes in sex steroids 32) . In other animals, e.g., rainbow trout, estradiol exposure decreased activities of T4-outer ring deiodination (ORD) and rT3-ORD in liver, but increased activity of T3-inner ring deiodination in kidney in both sexes 33) . In addition, estradiol treatment in immature rainbow trout, caused decrease of T3 in plasma 34) . As shown above, among general populations with various demographic characteristics, such as sex, age, and disease status, it is not easy to observe consistent directions of association. Moreover, potential effects of other TDCs that may present in the study populations cannot be ignored. Since the exposure 
PFASs exposure and thyroid hormone disruption in susceptible human populations
Many cross-sectional and often cohort studies have been conducted on susceptible populations including pregnant women and infants (Table 3) . These studies reflect the importance of thyroid hormones that play crucial roles in developing fetus and infants. Unlike big observation studies employing nationally representative populations, these studies on susceptible groups are smaller in population size, but often measured more diverse types of PFASs.
Generally, exposure levels of PFASs showed negative associations with thyroid hormones but positive association with TSH, although deviations were often noted. Chemicals, Health and Pregnancy study conducted among pregnant women of Vancouver Canada (n=152) reported a positive association between PFNA and TSH. Among TPOAb abnormal group, PFASs showed positive associations with TSH, and negative associations with fT4 35) . In a mother and child cohort of Norway, PFASs such as perfluorodecanoic acid (PFDA) and perfluoroundecanoic acid (PFUnDA) showed also negative associations with T3, and PFOS showed a positive association with TSH 36) . Similarly, in Norwegian pregnant women (n=930), PFOS that was measured at 18 weeks of pregnancy showed a positive association with TSH 37) . Hypothyroidism by PFASs exposure has also been reported in Asian countries. Among Taiwanese mothers of late pregnancy (n=285), maternal PFHxS levels showed a positive association with TSH, and PFASs such as PFNA, PFUnDA, or PFDoDA, showed negative associations with free and total T4 38) . In addition, maternal PFASs showed negative associations with cord total T3 and T4 levels, and maternal PFDA showed a negative association with cord total T3 levels. In Chinese mother and child pairs recruited in Beijing (n=157), maternal perfluorododecanoic acid also showed negative associations with free and total thyroid hormones. In addition, the levels of long chain PFASs, e.g., PFOA, PFNA, PFDA, PFUnDA, PFDoDA, PFHxS, or PFOS in cord serum, showed negative associations with maternal tT3 levels 39) . However, in the same population of China, many long chain PFASs measured in maternal serum showed negative associations with maternal TSH, not supporting hypothyroidism effects of PFASs exposure 39) . Some studies also reported similar inconsistent observations 22, 40, 41) . In Hokkaido cohort with matched mother and child pairs (n=39), PFOS levels measured in 24 weeks of pregnancy showed a negative association with maternal TSH, but a positive association with cord serum TSH. In another mother and child pair study (n=83), PFOA showed a positive association with T4 but only among female babies in the Netherlands (n=31) 40) . The association between short chain PFASs exposure and thyroid hormone levels was also reported.
In a retrospective cohort study between 2006 and 2010 in Korea (n=279), a positive association between PFPeA and thyroid hormones was observed, while PFHxS was also found to be positively associated in the same population 41) . Unlike studies on nationally representative population studies, studies on pregnant women and matching infants often measured shorter or longer carbon chain PFASs and reported their associations with thyroid hormones 39, 41, 42) . Especially for short carbon chain PFASs, however, limitations of representation of exposure windows should be considered in association studies because of their relatively shorter biological half-lives. Interpretation of cord thyroid hormone levels warrants caution as well, because cord hormone measurement may be influenced by thyroid hormones of maternal origin. Cord thyroid hormone levels can also be changing until shortly after the birth, by several delivery-related factors such as mode and time of delivery.
Proposed mechanisms of thyroid disruption
Most experimental studies and to lesser extent human observational studies support hypothyroidism effects of PFASs exposure, e.g., decrease of thyroid hormones, or increase of TSH 5) . PFASs can inhibit synthesis of thyroid hormones. PFASs are reported to decrease TPO activity in cells 44) . These compounds can also modulate thyroid hormone signaling and function of nuclear hormone receptor. In addition, PFASs can influence metabolism and excretion of thyroid hormones. PFASs can compete with T4 for binding with transthyretin (TTR) which is a transporter of thyroid hormones, in rat. Binding of PFASs with TTR results in increase of fT4 levels in circulation, leading to facilitated metabolic excretion of this hormone 45, 46) . PFOS upregulates T4 metabolic genes in rat, and also enhance hepatic glucuronidation and subsequently excretion of T4 46) .
Implications and conclusion
Human observational studies show that PFASs exposure among general human population is associated with altered thyroid hormone levels. However, it should be noted that observational studies based on general human populations have several intrinsic limitations that should be considered in interpretation of the results. First, one cannot rule out potential effects of other TDCs. Phthalates, bisphenols, PCBs, OCPs, and PBDEs have been suggested as TDCs among general human populations [47] [48] [49] . Exposure levels of PFASs among general populations tend to be low, and therefore, in the presence of other important TDCs that are not measured, the dose-response association can be significantly distorted often leading to wrong representation. Second, temporal comparability should be considered especially in cross-sectional or case-control studies 5) . Since most long-chain PFASs have long biological half-lives, one time measurement of the exposure may reflect relatively long PFAS, perfluoroalkyl substance; PFHxS, perfluorohexane sulfonic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonic acid; PFNA, perfluorononanoic acid; PFDeA, perfluorodecanoic acid; PFUnDA, perfluoroundecanoic acid; PFDoDA, perfluorododecanoic acid; PFHpA, perfluoroheptanoic acid; PFHxA, perfluorohexanoic acid; PFTrDA, perfluorotridecanoic acid; PFPeA, perfluoropentanoic acid; PFHpS, perfluoroheptane sulfonate; PFTeDA, perfluorotetradecanoic acid; PFUnA, perfluoroundecanoic acid; PFDoA, perfluorododecanoic acid; TSH, thyroid stimulating hormone; fT3, free triiodothyronine; fT4, free thyroxine; TPOAb, thyroid peroxidase antibody . www.e-apem.org period of exposure window. However, certain PFASs especially with shorter carbon chains have notably shorter biological half-lives and therefore lack temporal representativeness compared to their longer chain analogues. Moreover, influences of biological factors such as age and sex on effects of PFASs on thyroid hormones should add more complexity in elucidating underlying association. Various PFASs were found to be associated with thyroid hormone levels among susceptible populations such as pregnant women and infants as well as general population. PFASs may affect synthesis, metabolism and excretion of thyroid hormones. Even within normal range, changes in thyroid hormone levels during sensitive periods of developments may cause permanent damages in intelligence and neurodevelopment. Because of their notable persistence and toxicity, some PFASs, such as PFOS and PFOA have been regulated worldwide. However, there are very limited information on their substituting analogues, e.g., shorter or longer carbon chain PFASs. For these substitutes, toxicity information is lacking and exposure levels have not been characterized. Currently available information based on association studies with such substituting PFASs suggests that these chemicals may also disrupt thyroid among pregnant women and infants. Further investigations including exposure assessment and toxicity studies, along with their associations with thyroid related health effects among susceptible human populations are warranted.
